Skip to main content
Caplight Logo









Homedoctor

Homedoctor

Private
MadridHealthcare & Life Scienceshttps://homedoctor.es

Last Round

Growth Equity

Sep 26, 2024

Est. Valuation

$6.69M

Total Funding Raised

$5.02M

Company Overview

Homedoctor operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a Growth Equity round in September 2024.

Homedoctor is a telemedicine company that provides an advanced platform for immediate online medical consultations and remote patient monitoring.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Devices, Health IoT, Mental Health, Subscription Commerce

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Homedoctor Comparables

Compare Homedoctor with similar companies based on industry and business-model similarity.

Homedoctor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Docline
78%
TytoCare
78%
Ever Health
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Homedoctor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquitySep 26, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Homedoctor Investors

Notable investors and investment history

Homedoctor investors
InvestorRounds
Clave CapitalGrowth Equity
Q-ImpactGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 41% MoM, reaching 38K.

  • Feb 11, 2026

    Grew 26% QoQ, from 23 to 29 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Homedoctor Filings

Explore SEC and related filing metadata, where available.

Homedoctor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Homedoctor's valuation, stock price, and market status.

Is Homedoctor a public or private company?

Homedoctor is a private company.

What is the current stock price of Homedoctor?

Homedoctor is a private company, so its shares have no public market price. Caplight tracks Homedoctor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Homedoctor worth (valuation)?

Homedoctor's valuation is estimated at $6.7M based on funding round data.

Can I buy Homedoctor stock?

Homedoctor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Homedoctor's last funding round?

Homedoctor's most recent funding round was Growth Equity on September 26, 2024.

Who are the main investors in Homedoctor?

Key investors in Homedoctor include Q-Impact.

Will Homedoctor IPO soon?

No public IPO plans have been announced for Homedoctor.

How can I track Homedoctor secondary market activity?

Caplight tracks bids, offers, and trades in Homedoctor's shares on secondary markets.

Firmographic Details

HeadquartersMadrid
Employee Range17
Year Founded2017
Last FundingSep 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?